** Shares of Argenica Therapeutics rise as much as 12% to A$0.745, logs biggest intraday pct gain since Aug. 14
** Drug developer reports positive results in safety studies required for Investigational New Drug application $(IND.AU)$ by the U.S. FDA for its ARG-007 drug, aimed at treating acute ischemic stroke, a form of brain stroke
** IND application is a request for authorisation to administer experimental drugs to humans
** Co says opening an IND will enable it to conduct later stage clinical trials in the U.S.
** Stock up 36.3% YTD, as at 0551 GMT
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。